Phase II Trial of Erlotinib, Prior to Surgery or Radiation in Patients With Squamous Cell Cancers (SCC) of the Skin
Sponsor and Collaborators
M.D. Anderson Cancer Center
OSI Pharmaceuticals
Contact
Bonnie S. Glisson, MD, BS 713-792-6363
Continue Reading
Investigator
Bonnie S. Glisson, MD, BS UT MD Anderson Cancer Center
ClinicalTrials.gov Identifier
NCT01059305